These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2358266

  • 1. [Stereospecificity of lowering intraocular pressure using a locally administered carbonic anhydrase inhibitor].
    Diestelhorst M, Bechetoille A, Lippa E, Brunner-Ferber F, Krieglstein GK.
    Fortschr Ophthalmol; 1990; 87(2):131-3. PubMed ID: 2358266
    [Abstract] [Full Text] [Related]

  • 2. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N, Grehn F, Hennekes R, Garus H.
    Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
    [Abstract] [Full Text] [Related]

  • 3. [Additive effect of timolol and the local carbonic anhydrase inhibitor MK-417 (sezolamide)].
    Pfeiffer N, Greve E, Béchetoille A, Lippa EA, Jaquet-Müller F, Gunning F, Gerling J, Grehn F.
    Fortschr Ophthalmol; 1991; 88(6):846-7. PubMed ID: 1794818
    [Abstract] [Full Text] [Related]

  • 4. [Local carbonic anhydrase inhibitors MK-927 and Mk-417. Effect and tolerance].
    Gerling J, Pfeiffer N, Lippa E, Brunner-Ferber F, Grehn F.
    Fortschr Ophthalmol; 1990; 87(6):692-5. PubMed ID: 2086420
    [Abstract] [Full Text] [Related]

  • 5. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA, Polis A, Ostrov CS, Boyle JE.
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [Abstract] [Full Text] [Related]

  • 6. Results of the European Glaucoma Prevention Study.
    Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I, European Glaucoma Prevention Study (EGPS) Group.
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [Abstract] [Full Text] [Related]

  • 7. Dorzolamide influences the autoregulation of major retinal vessels caused by artificial intraocular pressure elevation in patients with POAG: a clinical study.
    Nagel E, Vilser W, Lanzl I.
    Curr Eye Res; 2005 Feb; 30(2):129-37. PubMed ID: 15814471
    [Abstract] [Full Text] [Related]

  • 8. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Apr; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
    Feldman RM, Tanna AP, Gross RL, Chuang AZ, Baker L, Reynolds A, Prager TC, Additivity Study Group.
    Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 13. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

  • 15. [MK-507 (L-671 152): local tolerance and effectiveness of a new local carbonic anhydrase inhibitor in healthy probands].
    Hofmann HM, Feicht B, Brunner-Ferber E, Lippa E, von Denffer H.
    Fortschr Ophthalmol; 1991 Feb; 88(5):513-4. PubMed ID: 1757042
    [Abstract] [Full Text] [Related]

  • 16. A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.
    Pfeiffer N, Hennekes R, Lippa EA, Grehn F, Garus H, Brunner-Ferber FL.
    Br J Ophthalmol; 1990 Jul; 74(7):405-8. PubMed ID: 2198931
    [Abstract] [Full Text] [Related]

  • 17. MK-927: a topically effective carbonic anhydrase inhibitor in patients.
    Bron AM, Lippa EA, Hofmann HM, Feicht BI, Royer JG, Brunner-Ferber FL, Panebianco DL, Von Denffer HA.
    Arch Ophthalmol; 1989 Aug; 107(8):1143-6. PubMed ID: 2667509
    [Abstract] [Full Text] [Related]

  • 18. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K, Orgül S, Flammer J.
    Curr Med Res Opin; 2003 Aug; 19(4):330-5. PubMed ID: 12841926
    [Abstract] [Full Text] [Related]

  • 19. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 20. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
    Lupinacci AP, Netland PA, Fung KH, Evans D, Zhao Y.
    Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.